Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta‐analysis of randomized controlled trials in patients with heart failure

Implantable device telemonitoring (DTM) is a diagnostic adjunct to traditional face‐to‐face hospital visits. Remote device follow‐up and earlier diagnoses facilitated by DTM should reduce healthcare utilization. We explored whether DTM reduces healthcare utilization over standard of care (SoC), without compromising patient outcomes.

[1]  S. Priori,et al.  HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. , 2008, Heart rhythm.

[2]  R. Schweikert,et al.  Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.

[3]  P. Heidenreich,et al.  Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.

[4]  Gillian D Sanders,et al.  Remote Monitoring of Implantable Cardioverter Defibrillators versus Quarterly Device Interrogations in Clinic: Results from a Randomized Pilot Clinical Trial , 2010, Journal of cardiovascular electrophysiology.

[5]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[6]  M. Borggrefe,et al.  Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart Failure , 2011, Circulation.

[7]  A. Boyle,et al.  The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. , 2011, Journal of the American College of Cardiology.

[8]  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2011, BMJ : British Medical Journal.

[9]  Howard Balshem,et al.  GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.

[10]  A. de Silvestri,et al.  Economic impact of remote patient monitoring: an integrated economic model derived from a meta‐analysis of randomized controlled trials in heart failure , 2011, European journal of heart failure.

[11]  Maurizio Marzegalli,et al.  Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable Defibrillators: The Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) Study , 2012, Circulation.

[12]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2011, BMJ : British Medical Journal.

[13]  Philippe Mabo,et al.  A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial) , 2011, European heart journal.

[14]  Cristina Masella,et al.  CONSORT-EHEALTH Checklist V1.6.2 Report , 2013 .

[15]  P. Lercher,et al.  Socio-economic effects and cost saving potential of remote patient monitoring (SAVE-HM trial). , 2013, International journal of cardiology.

[16]  Haran Burri,et al.  The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) Randomized Controlled Trial: Phase 1 Results on Dynamics of Early Intervention With Remote Monitoring , 2013, Journal of medical Internet research.

[17]  A. Chirico,et al.  Economic impact of remote monitoring on ordinary follow-up of implantable cardioverter defibrillators as compared with conventional in-hospital visits. A single-center prospective and randomized study , 2013, Journal of Interventional Cardiac Electrophysiology.

[18]  P. Thokala,et al.  Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs , 2013, BMJ Open.

[19]  Dominique Lacroix,et al.  Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  G. Hindricks,et al.  Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.

[21]  A. Bulava,et al.  The benefits of remote monitoring in long-term care for patients with implantable cardioverter-defibrillators. , 2014, Neuro endocrinology letters.

[22]  R. Mahajan,et al.  Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Clinical Outcomes. , 2015, Journal of the American College of Cardiology.

[23]  H. Heidbuchel,et al.  EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring , 2014, European heart journal.

[24]  G. Mairesse,et al.  Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.